QCMC
NVS icon

Quantum Capital Management (California)’s Novartis NVS Stock Holding History

Quantum Capital Management (California)’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$70K Sell
809
-109
-12% -$9.44K 0.08% 145
2020
Q2 		$80K Sell
918
-266
-22% -$23K 0.05% 189
2020
Q1 		$98K Sell
1,184
-30
-2% -$2.68K 0.07% 175
2019
Q4 		$115K Sell
1,214
-15
-1% -$1.35K 0.06% 193
2019
Q3 		$107K Buy
+1,229
New +$110K 0.05% 210
2015
Q3 		– Sell
-2,473
Closed -$218K – 171
2015
Q2 		$218K Buy
2,473
+48
+2% +$4.4K 0.03% 146
2015
Q1 		$214K Sell
2,425
-467
-16% -$41.4K 0.05% 160
2014
Q4 		$240K Buy
2,892
+62
+2% +$5.14K 0.05% 154
2014
Q3 		$239K Hold
2,830
– – 0.05% 156
2014
Q2 		$230K Buy
2,830
+90
+3% +$7.08K 0.04% 171
2014
Q1 		$209K Buy
+2,740
New +$200K 0.03% 164

Other funds holding NVS

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Quantum Capital Management (California)'s NVS Position: Q3 2020 in Review

Quantum Capital Management (California) reduced its Novartis (NVS) stake by 12% in Q3 2020, selling an estimated $9.44K and leaving 809 shares worth $70K. The position accounts for 0.08% of the portfolio, ranked #145.

Quantum Capital Management (California) first reported a position in NVS in Q1 2014 and has held it in 11 quarters since. The position peaked at $240K in Q4 2014. 1,118 funds tracked by Wall St. Rank hold NVS as of Q3 2020.

  • Quantum Capital Management (California) held 809 shares of Novartis worth $70K as of Q3 2020.
  • Quantum Capital Management (California) sold 109 Novartis shares in Q3 2020, an estimated $9.44K.
  • Novartis made up 0.08% of Quantum Capital Management (California)'s portfolio in Q3 2020, its #145 holding.
  • Quantum Capital Management (California) first reported a position in Novartis in Q1 2014 and has held it in 11 quarters since.
  • Quantum Capital Management (California)'s Novartis position peaked at $240K in Q4 2014.
  • 1,118 funds tracked by Wall St. Rank held Novartis as of Q3 2020.

Based on Quantum Capital Management (California)'s 13F filing for Q3 2020, filed 16 Nov 2020.